Dutch medtech market players advised to plan for DRGs - ARCHIVE VERSION
This article was originally published in Clinica
The Dutch healthcare system is undergoing major financing reform. Medical device manufacturers are expected to be affected by the changes, although the industry will not initially feel the brunt, according to the Dutch Association of Hospitals. It will however be impacted in the coming years, as the pressure grows for the purse holders to keep a tight rein on budgets in a more market-driven system.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.